Cargando…

Prevention of mother-to-child transmission of hepatitis B virus in Burkina Faso: Screening, vaccination and evaluation of post-vaccination antibodies against hepatitis B surface antigen in newborns

The low rate of screening for hepatitis B virus (HBV) in pregnant women is a highrisk factor for its vertical transmission. The objectives of this study were: i) to screen pregnant women for HBV infection; ii) vaccinate all children from birth against HBV regardless their mother HBV status; and iii)...

Descripción completa

Detalles Bibliográficos
Autores principales: Yelemkoure, Edwige T., Yonli, Albert T., Montesano, Carla, Ouattara, Abdoul Karim, Diarra, Birama, Zohoncon, Théodora M., Nadembega, Christelle W.M., Ouedraogo, Paul, Sombié, Charles, Soubeiga, Serge Theophile, Tao, Issoufou, Gansane, Adama, Amicosante, Massimo, Djigma, Florencia, Obiri-Yeboah, Dorcas, Pietra, Virginio, Simpore, Jacques, Colizzi, Vittorio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: PAGEPress Publications, Pavia, Italy 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6326159/
https://www.ncbi.nlm.nih.gov/pubmed/30687485
http://dx.doi.org/10.4081/jphia.2018.816
_version_ 1783386255405350912
author Yelemkoure, Edwige T.
Yonli, Albert T.
Montesano, Carla
Ouattara, Abdoul Karim
Diarra, Birama
Zohoncon, Théodora M.
Nadembega, Christelle W.M.
Ouedraogo, Paul
Sombié, Charles
Soubeiga, Serge Theophile
Tao, Issoufou
Gansane, Adama
Amicosante, Massimo
Djigma, Florencia
Obiri-Yeboah, Dorcas
Pietra, Virginio
Simpore, Jacques
Colizzi, Vittorio
author_facet Yelemkoure, Edwige T.
Yonli, Albert T.
Montesano, Carla
Ouattara, Abdoul Karim
Diarra, Birama
Zohoncon, Théodora M.
Nadembega, Christelle W.M.
Ouedraogo, Paul
Sombié, Charles
Soubeiga, Serge Theophile
Tao, Issoufou
Gansane, Adama
Amicosante, Massimo
Djigma, Florencia
Obiri-Yeboah, Dorcas
Pietra, Virginio
Simpore, Jacques
Colizzi, Vittorio
author_sort Yelemkoure, Edwige T.
collection PubMed
description The low rate of screening for hepatitis B virus (HBV) in pregnant women is a highrisk factor for its vertical transmission. The objectives of this study were: i) to screen pregnant women for HBV infection; ii) vaccinate all children from birth against HBV regardless their mother HBV status; and iii) evaluate after 7 months of birth the level of their AbHBs among babies who received HBV vaccine at birth. Serological markers of HBV (HBsAg, HBeAg, AbHBs, AbHBe, and AbHBc) were determined on venous blood samples from 237 pregnant women and their children using the Abon Biopharm Kit. One hundred and two (102) children received the three doses of the EUVAX B® vaccine respectively at birth, two months and four months of life. Seven months after delivery, venous blood samples were collected from mothers and their children. Antibodies against hepatitis B surface antigen (AbHBs) were measured in vaccinated children using the ELISA Kit AbHBs Quantitative EIA. DNA extraction was performed on samples from HBV-seropositive mothers and their children using the Ribo Virus (HBV Real-TM Qual) Kit and for Real Time PCR, the HBV Real-TM Qual Kit was used. Serological diagnosis in pregnant women revealed 22 (9.28%) hepatitis B surface antigen (HBsAg) positive samples of which 21 were positive for viral DNA by real-time PCR. Among the 22 HBsAg+ women, five (05) transmitted the virus to their children with a vertical transmission rate of 22.73%. A transmission rate of 23.81% (5/21) was found with the PCR method. Analysis of AbHBs levels revealed that 98.31% of the children had an average concentration of 218.07 ± 74.66 IU/L, which is well above the minimum threshold for protection (11 IU/L). This study has confirmed that vertical transmission of HBV is a reality in Burkina Faso and that vaccination at birth would significantly reduce this transmission.
format Online
Article
Text
id pubmed-6326159
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher PAGEPress Publications, Pavia, Italy
record_format MEDLINE/PubMed
spelling pubmed-63261592019-01-25 Prevention of mother-to-child transmission of hepatitis B virus in Burkina Faso: Screening, vaccination and evaluation of post-vaccination antibodies against hepatitis B surface antigen in newborns Yelemkoure, Edwige T. Yonli, Albert T. Montesano, Carla Ouattara, Abdoul Karim Diarra, Birama Zohoncon, Théodora M. Nadembega, Christelle W.M. Ouedraogo, Paul Sombié, Charles Soubeiga, Serge Theophile Tao, Issoufou Gansane, Adama Amicosante, Massimo Djigma, Florencia Obiri-Yeboah, Dorcas Pietra, Virginio Simpore, Jacques Colizzi, Vittorio J Public Health Afr Article The low rate of screening for hepatitis B virus (HBV) in pregnant women is a highrisk factor for its vertical transmission. The objectives of this study were: i) to screen pregnant women for HBV infection; ii) vaccinate all children from birth against HBV regardless their mother HBV status; and iii) evaluate after 7 months of birth the level of their AbHBs among babies who received HBV vaccine at birth. Serological markers of HBV (HBsAg, HBeAg, AbHBs, AbHBe, and AbHBc) were determined on venous blood samples from 237 pregnant women and their children using the Abon Biopharm Kit. One hundred and two (102) children received the three doses of the EUVAX B® vaccine respectively at birth, two months and four months of life. Seven months after delivery, venous blood samples were collected from mothers and their children. Antibodies against hepatitis B surface antigen (AbHBs) were measured in vaccinated children using the ELISA Kit AbHBs Quantitative EIA. DNA extraction was performed on samples from HBV-seropositive mothers and their children using the Ribo Virus (HBV Real-TM Qual) Kit and for Real Time PCR, the HBV Real-TM Qual Kit was used. Serological diagnosis in pregnant women revealed 22 (9.28%) hepatitis B surface antigen (HBsAg) positive samples of which 21 were positive for viral DNA by real-time PCR. Among the 22 HBsAg+ women, five (05) transmitted the virus to their children with a vertical transmission rate of 22.73%. A transmission rate of 23.81% (5/21) was found with the PCR method. Analysis of AbHBs levels revealed that 98.31% of the children had an average concentration of 218.07 ± 74.66 IU/L, which is well above the minimum threshold for protection (11 IU/L). This study has confirmed that vertical transmission of HBV is a reality in Burkina Faso and that vaccination at birth would significantly reduce this transmission. PAGEPress Publications, Pavia, Italy 2018-12-21 /pmc/articles/PMC6326159/ /pubmed/30687485 http://dx.doi.org/10.4081/jphia.2018.816 Text en ©Copyright E.T. Yelemkoure et al., 2018 http://creativecommons.org/licenses/by-nc/4.0/ This work is licensed under a Creative Commons Attribution NonCommercial 4.0 License (CC BY-NC 4.0).
spellingShingle Article
Yelemkoure, Edwige T.
Yonli, Albert T.
Montesano, Carla
Ouattara, Abdoul Karim
Diarra, Birama
Zohoncon, Théodora M.
Nadembega, Christelle W.M.
Ouedraogo, Paul
Sombié, Charles
Soubeiga, Serge Theophile
Tao, Issoufou
Gansane, Adama
Amicosante, Massimo
Djigma, Florencia
Obiri-Yeboah, Dorcas
Pietra, Virginio
Simpore, Jacques
Colizzi, Vittorio
Prevention of mother-to-child transmission of hepatitis B virus in Burkina Faso: Screening, vaccination and evaluation of post-vaccination antibodies against hepatitis B surface antigen in newborns
title Prevention of mother-to-child transmission of hepatitis B virus in Burkina Faso: Screening, vaccination and evaluation of post-vaccination antibodies against hepatitis B surface antigen in newborns
title_full Prevention of mother-to-child transmission of hepatitis B virus in Burkina Faso: Screening, vaccination and evaluation of post-vaccination antibodies against hepatitis B surface antigen in newborns
title_fullStr Prevention of mother-to-child transmission of hepatitis B virus in Burkina Faso: Screening, vaccination and evaluation of post-vaccination antibodies against hepatitis B surface antigen in newborns
title_full_unstemmed Prevention of mother-to-child transmission of hepatitis B virus in Burkina Faso: Screening, vaccination and evaluation of post-vaccination antibodies against hepatitis B surface antigen in newborns
title_short Prevention of mother-to-child transmission of hepatitis B virus in Burkina Faso: Screening, vaccination and evaluation of post-vaccination antibodies against hepatitis B surface antigen in newborns
title_sort prevention of mother-to-child transmission of hepatitis b virus in burkina faso: screening, vaccination and evaluation of post-vaccination antibodies against hepatitis b surface antigen in newborns
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6326159/
https://www.ncbi.nlm.nih.gov/pubmed/30687485
http://dx.doi.org/10.4081/jphia.2018.816
work_keys_str_mv AT yelemkoureedwiget preventionofmothertochildtransmissionofhepatitisbvirusinburkinafasoscreeningvaccinationandevaluationofpostvaccinationantibodiesagainsthepatitisbsurfaceantigeninnewborns
AT yonlialbertt preventionofmothertochildtransmissionofhepatitisbvirusinburkinafasoscreeningvaccinationandevaluationofpostvaccinationantibodiesagainsthepatitisbsurfaceantigeninnewborns
AT montesanocarla preventionofmothertochildtransmissionofhepatitisbvirusinburkinafasoscreeningvaccinationandevaluationofpostvaccinationantibodiesagainsthepatitisbsurfaceantigeninnewborns
AT ouattaraabdoulkarim preventionofmothertochildtransmissionofhepatitisbvirusinburkinafasoscreeningvaccinationandevaluationofpostvaccinationantibodiesagainsthepatitisbsurfaceantigeninnewborns
AT diarrabirama preventionofmothertochildtransmissionofhepatitisbvirusinburkinafasoscreeningvaccinationandevaluationofpostvaccinationantibodiesagainsthepatitisbsurfaceantigeninnewborns
AT zohoncontheodoram preventionofmothertochildtransmissionofhepatitisbvirusinburkinafasoscreeningvaccinationandevaluationofpostvaccinationantibodiesagainsthepatitisbsurfaceantigeninnewborns
AT nadembegachristellewm preventionofmothertochildtransmissionofhepatitisbvirusinburkinafasoscreeningvaccinationandevaluationofpostvaccinationantibodiesagainsthepatitisbsurfaceantigeninnewborns
AT ouedraogopaul preventionofmothertochildtransmissionofhepatitisbvirusinburkinafasoscreeningvaccinationandevaluationofpostvaccinationantibodiesagainsthepatitisbsurfaceantigeninnewborns
AT sombiecharles preventionofmothertochildtransmissionofhepatitisbvirusinburkinafasoscreeningvaccinationandevaluationofpostvaccinationantibodiesagainsthepatitisbsurfaceantigeninnewborns
AT soubeigasergetheophile preventionofmothertochildtransmissionofhepatitisbvirusinburkinafasoscreeningvaccinationandevaluationofpostvaccinationantibodiesagainsthepatitisbsurfaceantigeninnewborns
AT taoissoufou preventionofmothertochildtransmissionofhepatitisbvirusinburkinafasoscreeningvaccinationandevaluationofpostvaccinationantibodiesagainsthepatitisbsurfaceantigeninnewborns
AT gansaneadama preventionofmothertochildtransmissionofhepatitisbvirusinburkinafasoscreeningvaccinationandevaluationofpostvaccinationantibodiesagainsthepatitisbsurfaceantigeninnewborns
AT amicosantemassimo preventionofmothertochildtransmissionofhepatitisbvirusinburkinafasoscreeningvaccinationandevaluationofpostvaccinationantibodiesagainsthepatitisbsurfaceantigeninnewborns
AT djigmaflorencia preventionofmothertochildtransmissionofhepatitisbvirusinburkinafasoscreeningvaccinationandevaluationofpostvaccinationantibodiesagainsthepatitisbsurfaceantigeninnewborns
AT obiriyeboahdorcas preventionofmothertochildtransmissionofhepatitisbvirusinburkinafasoscreeningvaccinationandevaluationofpostvaccinationantibodiesagainsthepatitisbsurfaceantigeninnewborns
AT pietravirginio preventionofmothertochildtransmissionofhepatitisbvirusinburkinafasoscreeningvaccinationandevaluationofpostvaccinationantibodiesagainsthepatitisbsurfaceantigeninnewborns
AT simporejacques preventionofmothertochildtransmissionofhepatitisbvirusinburkinafasoscreeningvaccinationandevaluationofpostvaccinationantibodiesagainsthepatitisbsurfaceantigeninnewborns
AT colizzivittorio preventionofmothertochildtransmissionofhepatitisbvirusinburkinafasoscreeningvaccinationandevaluationofpostvaccinationantibodiesagainsthepatitisbsurfaceantigeninnewborns